Oklo Inc.

Fundamentals6.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Strong cash runway
  • No revenue
  • High valuation

AI
AI Summary

6.0

Oklo has shifted from a speculative SMR R&D story to a near-term commercialization play with prepaid hyperscaler funding, DOE approvals, and a meaningful cash runway, so investors must now price it as an execution- and timeline-focused investment rather than a pure technology option. Monitor Aurora's on-time 2027–28 commissioning, HALEU JV progress, and early isotope revenue ramps closely—any slippage will likely force dilutive financing and compress valuation, while on-schedule delivery would materially de‑risk the thesis.

Commercialization
ExecutionRisk
Liquidity‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Strong cash runway
  • No revenue
  • High valuation

OKLO has a strong, low‑leverage balance sheet with a large cash runway but zero revenue, significant operating and free‑cash‑flow losses funded by heavy financing, and a steep market valuation premium versus book and cash flows.

Overvalued
CashRunway

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last month avg
  • ~15% decline
  • Series of lower highs

OKLO is in a clear short-term downtrend—trading below its last month average after a ~15% fall from $63.83 to $53.97—facing support at $56–$59 and resistance at $63–$66, so downside risk persists until it reclaims the $63–$66 band.

bearish
watch
Support Level: $56–$59
Resistance Level: $63–$66

15% drop from $63.83 to $53.97 over last month with increased intraperiod range indicating elevated short-term volatility

Sentiment & News

7.0

Key News Insights:

  • Pre‑revenue status
  • Regulatory progress
  • Large price swing

Oklo is a cash‑rich, pre‑revenue SMR developer with strategic deals and regulatory progress but facing steep share declines and high execution/valuation risk.

SMR
Volatility

Regulatory approvals and strategic partnerships could unlock long‑term upside, but near‑term share performance will remain driven by execution risks and funding/runway visibility